Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 3569020)

1.

Stereochemical modelling studies of the interaction of antineoplaston A10 with DNA.

Hendry LB, Muldoon TG, Burzynski SR, Copland JA, Lehner AF.

Drugs Exp Clin Res. 1987;13 Suppl 1:77-81.

PMID:
3569020
3.
4.

Chemo-surveillance: a novel concept of the natural defence mechanism against cancer.

Liau MC, Szopa M, Burzynski B, Burzynski SR.

Drugs Exp Clin Res. 1987;13 Suppl 1:71-6.

PMID:
3569019
5.

Novel piperidinedione analogs as inhibitors of breast cancer cell growth.

Abou-Zeid LA, el-Mowafy AM, el-Ashmawy MB, Hendry LB, Abdelal AM, Badria FA.

Arch Pharm (Weinheim). 2000 Dec;333(12):431-4.

PMID:
11199474
7.

Studies of the release rate and bioavailability of antineoplaston A10 capsule.

Wang H, Xu W, Yuan Y.

Drugs Exp Clin Res. 1990;16(7):357-9.

PMID:
2092962
8.

Pharmacokinetic study of radioactive antineoplaston A10 following oral administration in rats.

Ashraf AQ, Liau MC, Kampalath BN, Burzynski SR.

Drugs Exp Clin Res. 1987;13 Suppl 1:45-50.

PMID:
3569015
9.

Chemoprevention by antineoplaston A10 of benzo(a)pyrene-induced pulmonary neoplasia.

Kampalath BN, Liau MC, Burzynski B, Burzynski SR.

Drugs Exp Clin Res. 1987;13 Suppl 1:51-5.

PMID:
3569016
10.

Antineoplaston treatment for advanced hepatocellular carcinoma.

Kumabe T, Tsuda H, Uchida M, Ogoh Y, Hayabuchi N, Sata M, Nakashima O, Hara H.

Oncol Rep. 1998 Nov-Dec;5(6):1363-7.

PMID:
9769368
11.

Induction of apoptosis in human hepatocellular carcinoma cells by synthetic antineoplaston A10.

Qu XJ, Cui SX, Tian Z, Li X, Chen MH, Xu WF, Inagaki Y, Deng YB, Makuuchi M, Nakata M, Tang W.

Anticancer Res. 2007 Jul-Aug;27(4B):2427-31.

12.

3-phenylacetylamino-2,6-piperidinedione inhibition of rat Nb2 lymphoma cell mitogenesis.

Wood JC, Copland JA, Muldoon TG, Hendry LB.

Proc Soc Exp Biol Med. 1991 Sep;197(4):404-8.

PMID:
1871151
13.

Pharmacokinetic study of radioactive antineoplaston A10 in rats and mice.

Xu W, Wang H, Yuan Y.

Drugs Exp Clin Res. 1990;16(7):351-5.

PMID:
2092961
14.

Synthesis of antineoplaston A10 analogs as potential antitumor agents.

Choi BG, Kim OY, Chung BH, Cho WJ, Cheon SH, Choi SU, Lee CO.

Arch Pharm Res. 1998 Apr;21(2):157-63.

PMID:
9875424
15.

Inhibition of spontaneous mouse mammary tumour development by antineoplaston A10.

Muldoon TG, Copland JA, Lehner AF, Hendry LB.

Drugs Exp Clin Res. 1987;13 Suppl 1:83-8.

PMID:
3569021
16.

Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma.

Tsuda H, Iemura A, Sata M, Uchida M, Yamana K, Hara H.

Kurume Med J. 1996;43(2):137-47.

17.

Inhibition of estrogen stimulated mitogenesis by 3-phenylacetylamino-2,6-piperidinedione and its para-hydroxy analog.

Copland JA, Hendry LB, Chu CK, Wood JC, Wrenn RW, Pantazis CG, Mahesh VB.

J Steroid Biochem Mol Biol. 1993 Oct;46(4):451-62.

PMID:
8217876
18.

Synthesis of Mannich bases of antineoplaston A10 and their antitumor activity.

Choi BG, Seo HK, Chung BH, Choi SU, Lee CO.

Arch Pharm Res. 1994 Dec;17(6):467-9.

PMID:
10319160
19.

Antiestrogenic piperidinediones designed prospectively using computer graphics and energy calculations of DNA-ligand complexes.

Hendry LB, Chu CK, Copland JA, Mahesh VB.

J Steroid Biochem Mol Biol. 1994 Apr;48(5-6):495-505.

PMID:
8180110
20.

Immune modulatory potentials of antineoplaston A-10 in breast cancer patients.

Badria F, Mabed M, El-Awadi M, Abou-Zeid L, Al-Nashar E, Hawas S.

Cancer Lett. 2000 Aug 31;157(1):57-63.

PMID:
10893443
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk